✨ Free AI Report
Shionogi & Co., Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Shionogi & Co., Ltd.
Company Research

Shionogi & Co., Ltd.: Business Overview, Financials & Competitive Analysis

Shionogi & Co., Ltd. is a Japanese pharmaceutical company best known for developing Crestor. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. With...

Analyst-debate audio for Shionogi & Co., Ltd.

AskCyborg analysts argue the bull and bear cases for Shionogi & Co., Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Established Japanese pharma with diversified pipeline and strong domestic presence offers moderate upside through specialty drugs...

Read the full analyst-debate transcript →
Industry Pharmaceuticals and Healthcare
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest Shionogi & Co., Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Shionogi & Co., Ltd. Overview

Pro stress-test →

Shionogi & Co., Ltd. is a Japanese pharmaceutical company best known for developing Crestor. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. With a market capitalization of $15.4B and trailing twelve month revenue of $2.93B, Shionogi maintains a significant presence across Japanese and global pharmaceutical markets.

Strategic Profile

Pro stress-test →

The company develops prescription drugs, over-the-counter drugs, and diagnostic products for therapeutic areas including metabolic disorders, pain/CNS, infectious diseases and cancer, and offers contract development and manufacturing facilities. Shionogi provides products and services in Japan, Europe, North America, and other regions, positioning itself as a diversified specialty and generic pharmaceutical manufacturer with global reach.

Competitive Landscape

Pro stress-test →

Shionogi competes with companies including Chugai Pharmaceutical, Astellas Pharma, Cipla, Novartis, and Takeda Pharmaceutical. The company holds a strong position in Japan's pharmaceutical market but faces intense global competition from larger integrated pharma firms with broader pipelines and R&D capabilities.

Industry Context

Shionogi & Co., Ltd. operates in Pharmaceuticals and Healthcare.

Key facts

Founded: 1878 · Headquarters: Osaka, Japan · Employees: 4,959 · Revenue: $2.93B-$3.0B · Market cap: $15.4B-$19.4B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Shionogi & Co., Ltd..

  • Shionogi is a partial owner of ViiV Healthcare, a pharmaceutical company specializing in HIV therapies
  • The company operates a network of subsidiaries across Japan, China, Taiwan, North America, and Europe, headquartered in Osaka
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • December 2025Shionogi completed corporate deal with Salubritas Therapeutics
  • September 2025Highlighted Japan's role in global health in discussion with Bill Gates on infectious diseases
  • +1 moreTrack every material event for Shionogi & Co., Ltd. as it happens. Explore monitoring →
Get alerted when Shionogi & Co., Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Takeda PharmaceuticalDiversified Japanese pharma with global reach→Astellas PharmaJapanese specialty pharmaceutical company→Chugai PharmaceuticalJapanese pharma focusing on oncology and diagnostics→NovartisGlobal innovative pharmaceutical company→

Compare Shionogi & Co., Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Shionogi & Co., Ltd. operates in Pharmaceuticals and Healthcare. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals and Healthcare research →
NEW · MCP server

Ask your AI assistant about Shionogi & Co., Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Shionogi & Co., Ltd. and its top competitor on Cyborg Score”
“What did Shionogi & Co., Ltd. do this quarter?”
“Is Shionogi & Co., Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Shionogi & Co., Ltd. do?+
Shionogi & Co., Ltd. is a Japanese pharmaceutical company best known for developing Crestor. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. With...
What is Shionogi & Co., Ltd.'s Cyborg Score?+
Shionogi & Co., Ltd. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Shionogi & Co., Ltd.'s main competitors?+
Named competitors include Takeda Pharmaceutical, Astellas Pharma, Chugai Pharmaceutical, Novartis. The full competitive landscape is in the AskCyborg report.
How can I get the full Shionogi & Co., Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Shionogi & Co., Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Shionogi & Co., Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals and Healthcare research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Hanmi Science Co., Ltd.5Shinpoong Pharmaceutical Co., Ltd.7Novartis AG